The Effect of Pre- And Post-Operative Prognostic Values on Patient Survival in Patients With Stomach Cancer
Research Article
DOI:
https://doi.org/10.5281/zenodo.17872112Anahtar Kelimeler:
Gastric Cancer, Lymph Node, Metastasis, C-reactive Protein (CRP), AlbuminÖzet
Objective: Prognostic values in gastric cancer have been frequently investigated in the literature. While some studies have yielded similar results, others have been the subject of debate. In our study, we examined several preoperative and postoperative parameters to evaluate factors that may influence prognosis. This study retrospectively evaluated the prognostic factors and investigated their impact on postoperative patient survival.
Methods: This retrospective study examined the clinical records, pathological results, and operative reports of 180 patients who underwent elective surgery for gastric cancer at the General Surgery Clinic of Kocaeli University Faculty of Medicine Research and Practice Hospital between January 2017 and December 2020.
Results: The impact of different surgical procedures on patient survival: 61.2% of patients who underwent total gastrectomy, 68.4% who underwent subtotal gastrectomy, and 43.7% who underwent other surgical procedures survived. Among patients with Stage 0+1 disease, 83.8% survived, whereas this rate was lower in patients with other stages (p = 0.007). These results suggest that tumor metastasis plays an important role in treatment effectiveness and patient survival (p = 0.004). The presence of lymph node metastases significantly impacts cancer patients' survival (p = 0.004). The rate of metastases in dissected lymph nodes was also significant in multivariate analysis (p = 0.041).
Conclusion: In this study, when evaluated univariately, four values (stage, presence of lymph node metastasis, serosa invasion, and metastasis rate in the dissected lymph node) were predictive of prognosis, whereas, when analyzed multivariately, only one value (metastasis rate in the dissected lymph node) was significant.
Objective: Prognostic values in gastric cancer have been frequently investigated in the literature. While some studies have yielded similar results, others have been the subject of debate. In our study, we examined several preoperative and postoperative parameters to evaluate factors that may influence prognosis. This study retrospectively evaluated the prognostic factors and investigated their impact on postoperative patient survival.
Methods: This retrospective study examined the clinical records, pathological results, and operative reports of 180 patients who underwent elective surgery for gastric cancer at the General Surgery Clinic of Kocaeli University Faculty of Medicine Research and Practice Hospital between January 2017 and December 2020.
Results: The impact of different surgical procedures on patient survival: 61.2% of patients who underwent total gastrectomy, 68.4% who underwent subtotal gastrectomy, and 43.7% who underwent other surgical procedures survived. Among patients with Stage 0+1 disease, 83.8% survived, whereas this rate was lower in patients with other stages (p = 0.007). These results suggest that tumor metastasis plays an important role in treatment effectiveness and patient survival (p = 0.004). The presence of lymph node metastases significantly impacts cancer patients' survival (p = 0.004). The rate of metastases in dissected lymph nodes was also significant in multivariate analysis (p = 0.041).
Conclusion: In this study, when evaluated univariately, four values (stage, presence of lymph node metastasis, serosa invasion, and metastasis rate in the dissected lymph node) were predictive of prognosis, whereas, when analyzed multivariately, only one value (metastasis rate in the dissected lymph node) was significant.
Referanslar
López MJ, Carbajal J, Alfaro AL, et al. Characteristics of gastric cancer around the world. Crit Rev Oncol Hematol. 2023;181:103841. doi: 10.1016/j.critrevonc.2022.103841
Machlowska J, Baj J, Sitarz M, Maciejewski R, Sitarz R. Gastric Cancer: Epidemiology, Risk Factors, Classification, Genomic Characteristics and Treatment Strategies. Int J Mol Sci. 2020;21(11):4012. doi: 10.3390/ijms21114012.
Yang K, Lu L, Liu H, et al. A comprehensive update on early gastric cancer: defining terms, etiology, and alarming risk factors. Expert Rev Gastroenterol Hepatol. 2021;15(3):255-273. doi: 10.1080/17474124.2021.1845140.
Tan Z. Recent Advances in the Surgical Treatment of Advanced Gastric Cancer: A Review. Med Sci Monit. 2019;25:3537-3541. doi: 10.12659/MSM.916475.
Song Z, Wu Y, Yang J, Yang D, Fang X. Progress in the treatment of advanced gastric cancer. Tumour Biol. 2017;39(7):1010428317714626. doi: 10.1177/1010428317714626.
Xia JY, Aadam AA. Advances in screening and detection of gastric cancer. J Surg Oncol. 2022;125(7):1104-1109. doi: 10.1002/jso.26844.
Karimi P, Islami F, Anandasabapathy S, Freedman ND, Kamangar F. Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev. 2014;23(5):700-13. doi: 10.1158/1055-9965.EPI-13-1057.
Orman S, Cayci HM. Gastric cancer: factors affecting survival. Acta Chir Belg. 2019;119(1):24-30. doi: 10.1080/00015458.2018.1453437.
Song Y, Hirata Y, Ajani JA, et al. Survival Outcomes in Patients with Resectable Gastric Cancer Treated with Total Neoadjuvant Therapy. Ann Surg Oncol. 2024;31(10):6918-6930. doi: 10.1245/s10434-024-15893-7.
Matsuoka T, Yashiro M. Bioinformatics Analysis and Validation of Potential Markers Associated with Prediction and Prognosis of Gastric Cancer. Int J Mol Sci. 2024;25(11):5880. doi: 10.3390/ijms25115880.
Komori K, Kano K, Ando S, et al. Clinicopathological Characteristics and Prognosis of Mucinous Gastric Cancer. Anticancer Res. 2023;43(6):2865-2871. doi: 10.21873/anticanres.16456.
Machlowska J, Maciejewski R, Sitarz R. The Pattern of Signatures in Gastric Cancer Prognosis. Int J Mol Sci. 2018;19(6):1658. doi: 10.3390/ijms19061658.
Mott T, Gray C. Gastric Cancer: Rapid Evidence Review. Am Fam Physician. 2025;111(2):140-145.
Liu X, Sun X, Liu J, Kong P, Chen S, Zhan Y, Xu D. Preoperative C-Reactive Protein/Albumin Ratio Predicts Prognosis of Patients after Curative Resection for Gastric Cancer. Transl Oncol. 2015;8(4):339-45. doi: 10.1016/j.tranon.2015.06.006.
Liu X, Sun X, Liu J, et al. Preoperative C-Reactive Protein/Albumin Ratio Predicts Prognosis of Patients after Curative Resection for Gastric Cancer. Transl Oncol. 2015;8(4):339-45. doi: 10.1016/j.tranon.2015.06.006.
Gökler C, İRkorucu O, Reyhan E, Bozkurt H, Görür M. Effect of tumor location and lymph node involvement on prognosis and survival in gastric cancer patients. Adıyaman Üniversitesi Sağlık Bilimleri Dergisi. 2020;6(2):248-257.
Bademler S, Üçüncü M, Bulut T, Asoğlu O. Metastatic Lymph Node Ratio (Nratio) is an İndependent Parameter of TNM Classification in Gastric Cancer Prognosis. BTDMJB. 2019;15(1):76-86.
Yokota T, Ishiyama S, Saito T, et al. Is tumor size a prognostic indicator for gastric carcinoma? Anticancer Res. 2002;22(6B):3673-3677.
Park JM, Ryu WS, Kim JH, et al. Prognostic factors for advanced gastric cancer: stage-stratified analysis of patients who underwent curative resection. Cancer Res Treat. 2006;38(1):13-18. doi: 10.4143/crt.2006.38.1.13.
Sun D, Xu H, Huang J. [Prognostic factors of lymph node-negative metastasis gastric cancer]. Zhonghua Wei Chang Wai Ke Za Zhi. 2017;20(2):190-194.
İndir
Yayınlanmış
Nasıl Atıf Yapılır
Sayı
Bölüm
Lisans
Telif Hakkı (c) 2025 Europeanatolia Health Sciences Journal

Bu çalışma Creative Commons Attribution 4.0 International License ile lisanslanmıştır.







